title: Antimalarial drug combination policy: a caveat.
authors.affiliation: Department of Immunology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand. chansudaw@thai.amedd.army.mil
authors.forename: C
authors.initials: C
authors.lastname: Wongsrichanalai
authors.forename: K
authors.initials: K
authors.lastname: Thimasarn
authors.forename: J
authors.initials: J
authors.lastname: Sirichaisinthop
mesh_terms: D000349:Africa; D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use*; D037621:Artemisinins; D000077332:Artesunate; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004351:Drug Resistance; D019353:Endemic Diseases; D006291:Health Policy; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy / Q000517:prevention & control; D015767:Mefloquine / Q000008:administration & dosage / Q000627:therapeutic use; D010963:Plasmodium falciparum / Q000187:drug effects; D012717:Sesquiterpenes / Q000008:administration & dosage / Q000627:therapeutic use; D013785:Thailand
chemical_list: D000962:Antimalarials; D037621:Artemisinins; D004338:Drug Combinations; D012717:Sesquiterpenes; D000077332:Artesunate; D015767:Mefloquine